Clinical trial
Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or…
NCT00040690 · Medical Research Council, Other · Completed
Key facts
| NCT number | NCT00040690 |
|---|---|
| Title | Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia |
| Official title | A Clinicopathological Study In Burkitts's And Burkitt-Like Non-Hodgkin's Lymphoma |
| Lead sponsor | Medical Research Council, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Leukemia, Lymphoma |
| Intervention type | Biological, Drug, Radiation |
| Interventions | filgrastim, cyclophosphamide, cytarabine, doxorubicin hydrochloride, etoposide, ifosfamide, leucovorin calcium, methotrexate, vincristine sulfate, radiation therapy |
| Enrollment | 120 |
| Start date | Nov 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Dec 19, 2013 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: